Larvol Delta - Phase-2-Trial-of-OncBioMunes-Immunotherapy-Cancer-Vaccine-ProscaVax-for-Prostate-Cancer-Patients-in-Active-Surveillance-Now-Open-for-Enrollment

Prostatac (PSA/IL-2/GM-CSF vaccine) - OncBioMune

http://www.globenewswire.com/news-release/2019/03/19/1757023/0/en/Phase-2-Trial-of-OncBioMune-s-Immunotherapy-Cancer-Vaccine-ProscaVax-for-Prostate-Cancer-Patients-in-Active-Surveillance-Now-Open-for-Enrollment.html

Mar 19, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next